DANIEL MOLLOY: Open Payments
NPI 1215255781 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,710 in 141 payments from 26 companies in 2025. Trend: 2023 $2,093 · 2024 $2,535 · 2025 $2,710
Food & beverage: $2,701Education: $10
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $324 |
| AstraZeneca Pharmaceuticals LP | 10 | $284 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $249 |
| Lilly USA, LLC | 12 | $234 |
| ABBVIE INC. | 20 | $227 |
| Exact Sciences Corporation | 8 | $195 |
| GlaxoSmithKline, LLC. | 11 | $163 |
| Otsuka America Pharmaceutical, Inc. | 7 | $157 |
| PFIZER INC. | 11 | $136 |
| Phathom Pharmaceuticals, Inc. | 5 | $112 |
Products named: Kerendia, MOUNJARO, FARXIGA, VRAYLAR, The Cologuard Plus Collection Kit, REXULTI, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
